Viability and apoptosis measured by imaging in BRAF(V600E/D) melanoma cell lines following treatment with combinations of two compounds (viability/apoptosis dataset 1 of 2) - Dataset (ID:20272)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule 1 | Small Molecule 2 | Small Mol 1 Concentration | Small Mol 2 Concentration | Small Mol Conc Unit | Time Point | Time Point Unit | Replicate | Total Number of Cells (Nuclei) | Number of Apoptotic Cells | Relative Viability | Mean Relative Viability | Apoptosis Fraction | Mean Apoptosis Fraction |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
A-375 | Vemurafenib | Saracatinib | 1.000 | 0.000 | uM | 72 | hr | 1 | 3640 | 140 | 0.1832 | 0.1915 | 0.0385 | 0.0418 |
A-375 | Vemurafenib | JNK-IN-8 | 0.100 | 1.000 | uM | 72 | hr | 1 | 5187 | 137 | 0.3177 | 0.2831 | 0.0264 | 0.0325 |
COLO 858 | Vemurafenib | Dasatinib | 0.100 | 0.316 | uM | 72 | hr | 1 | 1513 | 641 | 0.1246 | 0.1453 | 0.4237 | 0.3955 |
A-375 | Vemurafenib | Saracatinib | 1.000 | 0.316 | uM | 72 | hr | 1 | 2328 | 167 | 0.1131 | 0.1190 | 0.0717 | 0.0733 |
A-375 | Vemurafenib | Defactinib | 0.000 | 3.160 | uM | 72 | hr | 1 | 2168 | 298 | 0.0896 | 0.0889 | 0.1375 | 0.1262 |
COLO 858 | Vemurafenib | PF562271 | 1.000 | 0.000 | uM | 72 | hr | 1 | 1250 | 489 | 0.1372 | 0.1377 | 0.3912 | 0.4424 |
A-375 | Vemurafenib | Saracatinib | 1.000 | 1.000 | uM | 72 | hr | 1 | 1638 | 157 | 0.0775 | 0.0717 | 0.0958 | 0.0989 |
A-375 | Vemurafenib | JNK-IN-8 | 0.100 | 3.160 | uM | 72 | hr | 1 | 3804 | 246 | 0.2238 | 0.1826 | 0.0647 | 0.0764 |
COLO 858 | Vemurafenib | Dasatinib | 0.100 | 3.160 | uM | 72 | hr | 1 | 1844 | 660 | 0.1691 | 0.1486 | 0.3579 | 0.3478 |
A-375 | Vemurafenib | Saracatinib | 1.000 | 3.160 | uM | 72 | hr | 1 | 1317 | 141 | 0.0616 | 0.0571 | 0.1071 | 0.0996 |
A-375 | Vemurafenib | Dasatinib | 0.000 | 0.316 | uM | 72 | hr | 1 | 5949 | 318 | 0.2851 | 0.2714 | 0.0535 | 0.0654 |
COLO 858 | Vemurafenib | Dasatinib | 0.316 | 3.160 | uM | 72 | hr | 1 | 1347 | 812 | 0.0764 | 0.0748 | 0.6028 | 0.5989 |
A-375 | Vemurafenib | Saracatinib | 3.160 | 0.000 | uM | 72 | hr | 1 | 3381 | 232 | 0.1648 | 0.1538 | 0.0686 | 0.0753 |
A-375 | Vemurafenib | JNK-IN-8 | 0.316 | 0.000 | uM | 72 | hr | 1 | 3770 | 78 | 0.2322 | 0.2659 | 0.0207 | 0.0217 |
COLO 858 | Vemurafenib | Dasatinib | 0.316 | 0.316 | uM | 72 | hr | 1 | 1252 | 898 | 0.0506 | 0.0508 | 0.7173 | 0.7144 |
A-375 | Vemurafenib | Saracatinib | 3.160 | 0.316 | uM | 72 | hr | 1 | 2098 | 334 | 0.0923 | 0.0842 | 0.1592 | 0.1524 |
A-375 | Vemurafenib | Defactinib | 0.100 | 0.000 | uM | 72 | hr | 1 | 13441 | 248 | 0.6323 | 0.4565 | 0.0185 | 0.0200 |
COLO 858 | Vemurafenib | Dasatinib | 0.316 | 1.000 | uM | 72 | hr | 1 | 1374 | 845 | 0.0756 | 0.0722 | 0.6150 | 0.5817 |
A-375 | Vemurafenib | Saracatinib | 3.160 | 1.000 | uM | 72 | hr | 1 | 1524 | 308 | 0.0637 | 0.0584 | 0.2021 | 0.2015 |
A-375 | Vemurafenib | JNK-IN-8 | 0.316 | 0.316 | uM | 72 | hr | 1 | 3156 | 117 | 0.1912 | 0.2100 | 0.0371 | 0.0374 |
COLO 858 | Vemurafenib | Dasatinib | 1.000 | 0.316 | uM | 72 | hr | 1 | 840 | 724 | 0.0166 | 0.0153 | 0.8619 | 0.8976 |
A-375 | Vemurafenib | Saracatinib | 3.160 | 3.160 | uM | 72 | hr | 1 | 1136 | 225 | 0.0477 | 0.0453 | 0.1981 | 0.2134 |
A-375 | Vemurafenib | Dasatinib | 1.000 | 0.000 | uM | 72 | hr | 1 | 3774 | 124 | 0.1848 | 0.1953 | 0.0329 | 0.0349 |
WM-115 | Vemurafenib | Saracatinib | 3.160 | 3.160 | uM | 72 | hr | 1 | 1354 | 459 | 0.2327 | 0.2251 | 0.3390 | 0.3147 |
WM-115 | Vemurafenib | Saracatinib | 3.160 | 1.000 | uM | 72 | hr | 1 | 1476 | 418 | 0.2751 | 0.2647 | 0.2832 | 0.2681 |